Drug
FG 4592
FG 4592: highest development phase Phase 2/3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| FG-4592 NCT03303066 | Phase 2/3 | Anemia |
Latest
No recent events.
Follow FG 4592 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.